All In Biotech

Free tool

FAERS Monitor: Alvaiz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216774 or its brand name (Alvaiz, Eltrombopag Choline). Reports on generic versions are filed under their own applications.

Reports

3,893

Serious

3,620

93% of reports

Hospitalization

1,462

Death reported

632

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective550
  • off label use494
  • platelet count decreased426
  • thrombocytopenia254
  • product use in unapproved indication247
  • therapy non-responder210
  • death144
  • immune thrombocytopenia143
  • pneumonia139
  • pyrexia137
  • headache136
  • treatment failure115
  • anaemia108
  • sepsis106
  • pancytopenia103

Reports by year received

View as table
YearReports
20083
200947
201081
201147
201243
201387
2014146
2015246
2016130
2017138
2018203
2019293
2020245
2021310
2022293
2023306
2024332
2025463
2026480

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,266 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
immune thrombocytopeniaSignal143174.2147.923,688
therapy non-responderSignal21025.422.24,876
platelet count decreasedSignal42621.719.88,390
thrombocytopeniaSignal25412.310.92,633
pancytopeniaSignal10310.08.2823
treatment failureSignal1157.56.3644
product use in unapproved indicationSignal2475.44.8888
sepsisSignal1065.14.3351
anaemiaSignal1083.12.5149
off label useSignal4943.02.8707
pneumoniaSignal1392.32.0105
drug ineffectiveSignal5502.32.1408
pyrexiaSignal1372.11.883
headache1361.21.03
death1440.90.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.